EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC.

NAR Cancer · 2022 · PMC9155246 · PMID 35664541

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Interestingly, as shown in the heatmaps the NRF2 pathways genes showed an overall trend of downregulation upon EHF overexpression in both A253 and SCC25 cells, and increased expression in CAL-27 cells following the loss of EHF (Figure 7B ).

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.